Simply Wall St.
Possible Bearish Signals With HCA Healthcare Insiders Disposing Stock
➖
AI Sentiment
Neutral
4/10
- Home
- HCA
as of 02-06-2026 3:46pm EST
$500.74
$13.02
-2.53%
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2024, the firm owned and operated 190 hospitals, 124 freestanding outpatient surgery centers, and a broad network of physician offices, urgent-care clinics, and freestanding emergency rooms across 20 states and a small foothold in England.
| Founded: | 1968 | Country: | United States |
| Employees: | N/A | City: | NASHVILLE |
| Market Cap: | 106.0B | IPO Year: | N/A |
| Target Price: | $510.21 | AVG Volume (30 days): | 1.2M |
| Analyst Decision: | Buy | Number of Analysts: | 21 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 28.33 | EPS Growth: | 28.76 |
| 52 Week Low/High: | $295.00 - $527.55 | Next Earning Date: | 01-27-2026 |
| Revenue: | $75,600,000,000 | Revenue Growth: | 7.08% |
| Revenue Growth (this year): | 5.1% | Revenue Growth (next year): | 4.90% |
| P/E Ratio: | 17.71 | Index: | |
| Free Cash Flow: | 7.7B | FCF Growth: | +36.41% |
AI-Powered HCA Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 3 days ago
AI Recommendation
hold
Model Accuracy: 76.13%
76.13%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of HCA Healthcare Inc. (HCA)
HAZEN SAMUEL N
Sell
CEO
HCA Feb 3, 2026
Avg Cost/Share
$499.99
Shares
42,877
Total Value
$21,483,274.81
Owned After
60,437
Cuffe Michael S.
Sell
EVP and Chief Clinical Officer
HCA Feb 3, 2026
Avg Cost/Share
$498.09
Shares
1,500
Total Value
$747,135.15
Owned After
30,002.902
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| HAZEN SAMUEL N | HCA | CEO | Feb 3, 2026 | Sell | $499.99 | 42,877 | $21,483,274.81 | 60,437 | |
| Cuffe Michael S. | HCA | EVP and Chief Clinical Officer | Feb 3, 2026 | Sell | $498.09 | 1,500 | $747,135.15 | 30,002.902 |
Latest HCA Healthcare Inc. News
HCA Breaking Stock News: Dive into HCA Ticker-Specific Updates for Smart Investing
GuruFocus.com
Diamond Hill Capital's Strategic Moves: HCA Healthcare Inc. Reduced by 1.25%
➖
AI Sentiment
Neutral
4/10
Zacks
Centene Incurs Q4 Loss, Revenues Up YoY due to PDP Business Strength
➖
AI Sentiment
Neutral
4/10
Zacks
Ensign Group Q4 Earnings Beat Estimates on Growing Occupancy
📈
AI Sentiment
Highly Positive
8/10
MT Newswires
Argus Adjusts Price Target on HCA Healthcare to $560 From $530, Maintains Buy Rating
📊
AI Sentiment
Positive
7/10
Compare HCA vs Leading Stocks
See how HCA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "HCA HCA Healthcare Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.